PMID: 6978666Jan 1, 1981Paper

The effect of anti-thymocyte antiserum in progressive myasthenia gravis

Annals of the New York Academy of Sciences
B Pirofsky

Abstract

The therapeutic effect of goat anti-human thymocyte antiserum globulin (ATG) was assessed in ten patients with myasthenia gravis. Five patients had undergone prior thymectomy. All subjects had far-advanced, debilitating and progressing disease poorly responsive to classic anticholinesterase therapy. Prolonged, low dose ATG therapy was used with 1.0-2.6 grams/protein administered intramuscularly over a 28-73 period. Depression of cellular immunity was observed with anti-thymocyte antiserum was more profound in patients with a prior thymectomy. Therapeutic responses of varying degrees were noted in 8 out of 10 patients. Completion of a course of ATG and discontinuation of the drug did not lead to acute relapse states. Follow-up examinations for over five years have been maintained. A mean remission period of approximately two years was observed. It is suggested that this therapy deserves further evaluation. Subjects with prior thymectomy and progressive disease may represent the most ideal candidates.

References

Jan 1, 1976·Annals of the New York Academy of Sciences·J A SimpsonH M Dick
Jan 1, 1976·Annals of the New York Academy of Sciences·G Birnbaum, P Tsairis
Jan 1, 1976·Annals of the New York Academy of Sciences·A E PapatestasP Kornfeld
Jan 1, 1979·Neurology·B PirofskyR L Baker
Jan 1, 1976·Annals of the New York Academy of Sciences·R R Almon, S H Appel
Mar 1, 1974·The American Journal of Medicine·B PirofskyA August
Sep 15, 1971·Annals of the New York Academy of Sciences·F F Foldes, G H Glaser
Sep 1, 1972·Thorax·F R Edwards, A Wilson

❮ Previous
Next ❯

Citations

Jan 1, 1985·Journal of Neurology·D P Richman
Jan 1, 1982·Springer Seminars in Immunopathology·M E Seybold, J M Lindstrom
Jan 1, 1987·Annals of the New York Academy of Sciences·T R Johns
Mar 1, 1990·Arquivos de neuro-psiquiatria·J L De Assis
Jan 30, 2018·Annals of the New York Academy of Sciences·Henry J KaminskiRami M Algahtani
Nov 1, 1984·Annals of Neurology·A G Engel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved